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Abstract
Background: Annual mass drug administration (MDA) over five years is the WHO’s recommended strategy to eliminate
lymphatic filariasis (LF). Some experts, however, consider that longer periods of treatment might be necessary in certain
high prevalence and transmission environments based upon past unsuccessful field experience and modelling.
Methodology/Principal Findings: To evaluate predictors of success in a LF control program we conducted an ecological
study during a pre-existing MDA program. We studied 27 villages in Lihir Island, Papua New Guinea, from two areas with
different infection rates before MDA. We undertook surveys to collect information on variables potentially having an
influence on the outcome of the program, including epidemiological (baseline prevalence of infection, immigration rate),
entomological (vector density) and operational (treatment coverage, vector control strategies) variables. The success in a
village was defined using variables related to the infection (circulating filarial antigenemia prevalence ,1%) and
transmission (antigenemia prevalence ,1 in 1000 children born since start of MDA). 8709 people were involved in the MDA
program and average coverage rates were around 70%. The overall prevalence of filariasis fell from an initial 17.91% to
3.76% at round 5 (p,0.001). Viewed on a village by village basis, 12/27 (44%) villages achieved success. In multivariate
analysis, low baseline prevalence was the only factor predicting both success in reducing infection rates (OR 19,26; CI 95%
1,12 to 331,82) and success in preventing new infections (OR 27,44; CI 95% 1,05 to 719,6). Low vector density and the use of
an optimal vector control strategy were also associated with success in reducing infection rates, but this did not reach
statistical significance.
Conclusions/Significance: Our results provide the data that supports the recommendation that high endemic areas may
require longer duration MDA programs, or alternative control strategies.
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Introduction
Lymphatic filariasis (LF), caused by the mosquito-borne
nematode Wuchereria Bancrofti, is a major public-health problem
in many tropical and subtropical regions. Papua New Guinea
represents the biggest remaining challenge for elimination of the
disease. The Global Program to Eliminate Lymphatic Filariasis
(GPELF) was launched in 1997. In the Pacific, the World Health
Organization (WHO) has implemented from 1999, the Pacific
Program to Eliminate Lymphatic Filariasis (PacELF) bringing
together 22 countries and territories, in a common effort to
eliminate the disease [1,2]. The PacELF strategy is based on five
rounds of mass drug administration (MDA), monitored by a
prevalence survey to assess the impact at completion of the last
round [3,4]. Therefore, the assessment is designed to conclude
whether to stop or to continue MDA after round 5. The rationale
of this approach is to suppress microfilaremia (mf) in infected
populations and bring the infection level down below a threshold
that will prevent resurgence of infection and ultimately lead to
interruption of transmission [5].
The exact infection level to achieve LF elimination in different
endemic regions remains unknown, such that it is difficult to
predict or decide when to stop ongoing MDA programs. Previous
reports have suggested that residual filarial infections disappear
when prevalence rates fall to less than 1% but it may vary
depending on specific ecological conditions [6,7]. Moreover, some
programs which have achieved this threshold have reported
evidence of ongoing transmission, as measured by antibody or
antigen prevalence in children aged 2–4 years and mosquito
infection rates [8,9]. The current recommendation of the PacELF
is that programs should reach an antigenemia level below 1% and
that less than 1 in 1000 children born since start of MDA should
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recently been changed to a level below 2% in areas where the
main vector is an anopheline [4].The optimal duration of MDA
programs has also not been established. Mathematical models
suggest that 4 to 6 years of treatment should be sufficient [10].
However, several programs have reported evidence of failure to
control the infection, as indicated by mf and circulating filarial
antigenemia prevalence rates after completing five annual rounds
of MDA [11–14].
Numerous attempts have been made to establish which
variables may influence the outcome of a program. Some
variables, such as the coverage of the target population
[9,15,16], the drug regimen employed [5,17–20], and the
integration of vector control measures [21–23], are controllable.
Other biological and epidemiological variables, such as the initial
prevalence of mf in an area and the vectorial abundance of the
mosquito, are less amenable to modification. All the above
mentioned factors need to be taken into consideration when
developing an elimination strategy [24].
The aim of this study was to estimate success rates of the
program to eliminate lymphatic filariasis (PELF) in villages from
different areas and to identify determinants of success affecting a
PELF’s outcome.
Methods
Data for this ecological study were collected at a community-
level during the delivery of an MDA program in villages of Lihir
Island, Papua New Guinea. The program was closely monitored
epidemiologically, entomologically, and through laboratory studies
as outlined below. Together with drug administration we
undertook different types of surveys including village surveys to
collect information about variables potentially having an influence
on the outcome of the program; circulating filarial antigenemia
(CFA) prevalence surveys to assess the infection status and new
infections since start of MDA; and mosquito surveys to determine
mosquito abundance. CFA prevalence of the entire population
was reassessed once after round 5.
The surveys were administered to the entire population of 27
villages in two regions of Lihir Island that had different infection
prevalence rates before MDA was initiated. The study villages are
only separated by between 1 and 3 kilometres from each other,
however they constitute independent transmission zones as the
vector species, Anopheles farauti, is generally considered incapable of
flying more than 700 metres [25]. Many residents had been
previously treated with diethylcarbamazine citrate (DEC) alone in
1995 during a campaign started by the New Ireland provincial
government which continued for a short time [25]. However, ten
out of twelve villages located in the swampy regions of the west
coast recorded prevalence levels of filariasis as high as 20–60% in
2003. The other study villages on the dry savannah grassland of
the north-east had rates 3–7 times lower than those in the west. In
addition, the eastern area of the island in the vicinity of Londolovit
has been host to a mining operation by LGL Australia since 1996.
This has seen the influx of approximately 2000 workers from other
areas of PNG and internationally, and a considerable unofficial
migrant population from surrounding regions. There has been a
degree of local development in the mine affected area.
Field teams consisting of a physician, a technician, and a local
health worker visited the villages at spot check sites, annually. Prior
to each visit, efforts were made to educate the public to the
program’s aims through health educators who disseminated
information about LF at community meetings and through public
notices, in cooperation with church and village leaders. MDA
comprised the WHO-recommended regimen of a single oral dose
of DEC (6 mg/kg body weight) and albendazole (400 mg
regardless of weight) under direct observation. Simultaneously
the teams collected the blood samples and recorded on a register
epidemiological data and coverage information. Some people
agreed to receive MDA but refused to provide blood samples. The
observed coverage rates were based on the number of subjects seen
to ingest the tablets and calculated on the basis of the total eligible
population. However, a coverage survey was not carried out to
verify the coverage achieved. The global programme uses
coverage data reported by surveys, while PacELF uses data from
registers [1]. The source of data chosen to calculate the total
population was the local census carried out among all island
villagers annually. We classified as high drug coverage rate all
villages where the percentage of treated population was estimated
at more than 70%. Migration from other areas was considered to
be low when it involved less than 5% of the village population.
Circulating filarial antigenemia (CFA) was assessed with a rapid-
format antigen card test (Filariasis Now, Binax Inc., Portland,
Maine, USA) together with the first and after fifth round of MDA.
While microfilaremia is the gold standard for monitoring filarial
infection, PacELF guidelines are based on the use of the antigen
test in a community-wide survey [1], as this is a simple card test
with a high reported sensitivity (98.5%) and specificity (100%)
[26,27], and provides the additional advantage of allowing
daytime blood sampling. We defined the prevalence rate of CFA
as the number of people with a positive antigen test divided by the
number of people tested. A low endemicity was defined as a CFA
positivity rate in the population of less than 10%.
Mosquitoes were collected to assess the vector biting activity
before the first round of MDA (January 2003). Indoor human
landing catches of the vector mosquito, Anopheles farauti [25], were
conducted from sunset to sunrise (18:30–06:30 h). With the help of
a simple aspirator mosquitoes were caught when they landed on a
human volunteer for taking a blood meal. A monthly biting rate
(MBR) was computed by multiplying the number of mosquitoes
contacting a man per 24 hours with the number of days in the
month. Vector density was considered to be low when the MBR
was under 100 bites/person/month.
A supplementary vector control strategy involving anti-mosqui-
to measures was put in place. Source reduction of potential
Author Summary
Large-scale intervention programmes to control filariasis
are currently underway worldwide. However, a major
unresolved question remains: what is the appropriate
duration for these programmes? Recent theoretical work
and clinical field experience has highlighted how the
ecological diversity between different endemic regions
hinders decision making processes of when to stop
ongoing MDA programs. The goal of our study was to
identify the factors determining success for a five year LF
elimination program. We undertook different types of
surveys together with a pre-existing MDA program in
villages from two regions that had different infection
prevalence rates. Our study shows that the five yearly
cycles of MDA could neither eliminate the disease nor stop
transmission in the high prevalence villages, such that low
baseline lymphatic filariasis prevalence has a positive
influence on the outcome of a program. Thus, the study
provides data supporting the recommendation that in
certain high prevalence and transmission environments
more sustained efforts may be necessary.
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distribution of long-lasting insecticide-treated netting materials
(LLITNs) were promoted in the entire island. However, indoor
spraying of residual pyrethroids was used only in certain villages
located in the vicinity of the Lihir Gold mine. We defined an
optimal vector control strategy as one where all of these anti-
mosquito tools were employed. Our study did not assess
compliance in the use of bed nets, nor assess the effectiveness of
local mosquito control measures.
The success of the program in a village was defined using
variables related to the infection (reaching antigenemia level below
1%) and transmission (less than 1 in 1000 children born in the
community since start of MDA having infection measured by
antigenemia).
Statistical analysis
Data entry was undertaken with EpiInfo software (version 6),
with field limits and double data entry. We analysed demographic
data (age and sex), migration from other areas, the initial
endemicity of infection (prevalence rate), the vector abundance,
treatment coverage (number of tablets distributed), the use of
adjuvant vector control strategies and the outcome of the
elimination program. Univariate analyses of data from the villages
were performed using the x
2 test for categorical data, and the t-test
or Mann–Whitney U-test for continuous data. Predictors for
success of PELF in controlling the infection prevalence were
analysed by multivariate logistic regression, which included the
following variables: low baseline prevalence, low migration, low
vector density, high treatment coverage, and optimal vector
control strategy. Predictors of success in stopping the transmission
were also analysed by logistic regression analysis, which included
the variables: average age ,20 years, low endemicity of infection,
low vector density and high treatment coverage. Odds ratios and
95% confidence intervals are presented. All multivariate logistic
analyses were done using Firth’s method to overcome problems of
separation in small samples [28]. Data were analysed using SAS
9.1.3 (SAS Institute Inc., Cary, NC, USA) and SPSS 14.0 (SPSS
Inc., Chicago, IL, USA).
Reporting of the study has been verified in accordance with the
STROBE checklist (provided as Checklist S1).
Ethical clearance
Ethics approval for this study, including the oral consent
process, was obtained from the Papua New Guinea Ministry of
Health Medical Research Advisory Committee. The consent
sought was verbal because of the high illiteracy rate in rural
population, and it was documented on case report forms. Study
personnel informed prospective study participants about the study
by reading them a consent document in the local language. All
subjects provided informed consent at every stage of the study
including for collection of samples, interviews, and individuals
involved in calculating monthly bite rates. Participation by
children required consent from at least one parent and the child’s
assent.
Results
The annual census in the year 2003 estimated that 8709 people
lived in the 27 villages which were part of the study and that were
visited and treated annually over a period of 5 years. At the
baseline survey, a total of 6037 individuals were registered
corresponding to 70.0% of the entire population (as determined
by the 2003 census). 50% of the villagers were male, and the mean
age was 20.6 years. Reported coverage in 2004–2007 for MDAs
2–5 was 69.8%, 73.0%, 74.1% and 71.5% respectively. Drug
coverage remained stable over time and it was similar in all the
territories, with an average of 72,9% in eastern coast villages and
67,4% in western coast villages (p=0.35). The reason why 26% to
30% of the target population were not treated is that they were not
available at the time of the medical team visit (i.e. working, visiting
relatives) or that they were ineligible persons (3.0% to 6.0% of the
de facto population), including pregnant women and children
younger than 2 years old or of weight less than 10 kg.
The demographic and epidemiological data and program
operational details of the 27 villages are shown in Figure 1.
Almost half (44,4%) of the villages had migration rate over 5% of
the total population, 12 (80.0%) of them were villages from the
eastern coast. The migrants mainly came from low endemic areas
for filariasis such as the PNG mainland, and from the small islands
surrounding Lihir. The details of treatment coverage were
recorded during all the five rounds of treatment and the average
calculated. Individually, 55.6% of the villages had a high drug
coverage, including 60,0% (9/15) in the eastern coast group and
50,0% (6/12) in the western coast group.
Mosquito transmission indices varied significantly in different
villages. The highest indices of transmission were observed in
villages located in the swampier regions of the west coast with a
MBR median (interquartile range) of 460.8 (1812.6) bites/person/
month, compared to 57.6 (180.0) in the east coast. These data
indicate that there is regional micro-variation in the intensity and
temporal pattern of filariasis transmission. It is noteworthy that
only nine villages (33.0%) used indoor residual spraying and
therefore achieved an optimal vector control strategy.
Table 1 shows data for filarial infection rates before and after
the PELF. Overall, all variables showed significant decreases from
pre-MDA to round 5 (p,0.001). The analysis of data from all
villages shows a significant decrease in circulating filarial
antigenemia (CFA) over this period from a mean prevalence of
17.9% to 3.8% (p,0.001). Pre-MDA CFA prevalence rates were
much higher in the Western than in the Eastern territories. The
mean prevalence of infection was 7.7% and 0.8% in eastern
villages, and 30.7% and 7,5% in western villages in the pre-MDA
and at completion of round 5, respectively (table 1). Pre-MDA
antigenemia prevalence rates in children under 5 years were not
significantly different in the western village schools and in the
eastern village schools (60.1 vs 31.0 in 1000; p=0.10). Rates of
circulating filarial antigenemia in under 5 y.o. children fell more
rapidly in the less heavily infected eastern villages than in the
western villages (30.0 vs 0.95 in 1000; p,0.01). Twenty-one
children with a positive result out of 700 tested were identified in
the Western villages after round 5.
As shown in figure 2, the CFA prevalence in individual villages
ranged from 1.1% to 58% and 0 to 17%, in the pre-MDA and
post-MDA surveys respectively. PELF had a successful outcome
on infection prevalence control in 12 of the 27 villages (44.4%),
whereas it failed in the remaining 15 (55.5%). Transmission,
assessed on the incidence of new infections, was successfully
controlled in 19 (70,3%) villages. On univariate analysis (table 2),
numerous factors were found to be significantly associated with
PELF success on the control of infection status including low
baseline prevalence, low vector abundance, and implementation of
an optimal vectorial control. A low percentage of migration,
unexpectedly, was found to be a risk factor. On multivariate
analysis (table 2), the only independent factor predicting PELF
infection control success was low endemicity of infection (OR
19.26; CI 95% 1.12–331.82). Table 3 shows the univariate and
multivariate predictors associated with transmission control
success. Low endemicity of infection (OR 27.44; CI 95% 1.05–
Impact of a Filariasis Control Program
www.plosntds.org 3 August 2011 | Volume 5 | Issue 8 | e1286719.6) was again the only factor independently associated with
transmission control success.
Discussion
In the present study the overall prevalence of circulating filarial
antigenemia was reduced by 79.0%. Despite undeniable success,
the program did not achieve its very ambitious goals based on the
PacELF recommendations, with post treatment prevalence
remaining at 3.8% and 14 new infections per 1000 children born
since start of MDA. This overall failure was the result of the
intervention specifically failing in some villages. Understanding
what factors lead to success or failure when the intervention is
applied to a specific setting may help improve the MDA program.
Our findings reveal that in Lihir, the baseline infection status was
an important factor influencing on the outcome of the PELF. Our
discussion will focus on possible explanations for this observation
and the influence of other factors on the outcome.
The first objective of our study was to test the hypothesis that
bancroftian filariasis can be eliminated from communities by
yearly cycles of MDA with diethylcarbamazine and albendazole.
Over all, success in controlling the infection and in stopping
transmission was confirmed in 45% and 70% of the villages,
respectively, most of them located in the eastern coast. The eastern
coast villages had low baseline levels of filariasis endemicity,
whereas the western coast villages had very high baseline rates that
were more typical of filariasis endemic islands in the Western
Pacific Region [2]. Our data suggest that five rounds of MDA will
not have eliminated filariasis in the western study area. However
the observed post-treatment antigen prevalence rates are unlikely
to sustain transmission as the vector-parasite relationship in Lihir
is extremely fragile involving the An. Farauti which is one of the
least efficient vectors in the world. The cut-off point for
interruption of transmission in the PacELF region was based on
the fact that transmission in most of the Pacific island countries is
carried out by the highly efficient Culex and Aedes mosquitoes.
The second major objective of our study was to evaluate the
factors having a positive influence on the markers of success. In
our study the most prominent determinant of success was low
baseline prevalence of infection. Low vector density appeared to
have an association but did not reach statistical significance. The
sample size, as it is based on the number of villages, is
unfortunately low and may have caused the study to be
underpowered when trying to determine the significance of this
Figure 1. Baseline epidemiological, infection status and entomological data and program coverage details of 27 villages, Lihir
Island.
doi:10.1371/journal.pntd.0001286.g001
Table 1. Effect of MDA on circulating filarial antigenemia prevalence rates on Lihir Island.
Infection prevalence Ongoing transmission (new infections detected)
Number of
people tested
Antigenemia prevalence
rate
a (%[SD])
Number of
children tested
Positive Antigenemia in
1000 children
b (%[SD])
East coast study area
Pre-MDA 3009 7.67 (8.77) 537 30.98 (49.19)
MDA round 5 3799 0.76 (0.92) 1006 0.96 (3.68)
West coast study area
Pre-MDA 1969 30.71 (15.87) 462 60.14 (37.36)
MDA round 5 2464 7.51 (3.77) 700 30.00 (29.96)
Total
Pre-MDA 4978 17.91 (16.86) 999 43.94 (45.95)
MDA round 5 6263 3.76 (4.26) 1706 13.86 (24.57)
aAntigenemia prevalence rate in a large size sample from the whole treated population. Some people agreed to receive MDA but refused to provide blood samples.
bAntigenemia prevalence rate in children under 5 years old which represents new infections since start of MDA.
doi:10.1371/journal.pntd.0001286.t001
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having a positive influence in the outcome of a PELF. These
include high coverage of the targeted population [9,15,16], low
levels of migration from other areas and integration of the different
available control strategies into the program [21,22]. In the
current study however, these variables did not show an association.
Prior to the current study there has been little reliable clinical
evidence comparing low prevalence communities with high
prevalence populations. Our study followed a large cohort,
contained detailed information about risk factors and outcomes
and established comparisons among several independent areas of
transmission. The current study also had the advantage of being
conducted in an area of Papua New Guinea with a relatively high
rate of infection and transmission, and a pronounced inter-area
variation in prevalence. Moreover, an island population such as
Lihir presents more ideal conditions for epidemiological studies
and evaluation of control programs than large land areas. This
study has the limitations of an observational ecological study, and
Figure 2. Percentage of Infected people, in Lihir Island Villages, in the pre-MDA and post-MDA surveys. NOTE. The diameter of the
circles is proportional to the estimated prevalence of Lymphatic filariasis, implying that every line corresponds to an increase in prevalence of 5%.
doi:10.1371/journal.pntd.0001286.g002
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factors need to be considered with caution. Also, data for some
factors which may influence success rates (e.g. number of persons
per household, use of bednets) were not collected. However, the
analyses performed controlling for the widely recognized prime
predictors, the strong and similar results obtained in the
multivariate analyses for two different markers of success, and
the use of specific techniques to obtain unbiased risk estimates with
small samples allow us to have confidence in the results obtained.
The percentage of the population covered is an important factor
in determining the success of a PELF that has been previously
analysed [9,15,16]. We developed a timely and coordinated drug
delivery strategy that included elements of community information
and education in an attempt to achieve widespread acceptance of
drug treatment and the DOT (Directly Observed Therapy)
distribution method. We made an effort to reach those groups of
individuals who are recognized to be at risk of systematic non-
compliance during MDAs including children, the upper socioeco-
nomic classes, young men and the elderly. We achieved an overall
70% reported population treatment coverage which was probably
underestimated, since it was calculated using the number of people
in the local census. In the multivariate analysis the coverage was
not associated with any of the markers of success. This is likely due
to the similar levels of coverage achieved in all the villages in the
current program.
The lack of influence of population migration in this study may
be explained by the demographics of the migrant population. The
presence of the gold mining operation at Lihir has attracted a large
Table 2. Association between characteristics of villages and program related factors and PELF success to control infection
prevalence.
Factor
Villages where PELF
succeeded
(N=12)
Villages where
PELF failed
(N=15) Univariate Analysis Multivariate Analysis
OR (95% CI) P value* OR (95% CI) P value*
Demographic data
average age ,20 yr old 3 (25.0) 6 (40.0) 0.5 (0.09–2.64) 0.41
sex, male-female rate .0.50 7 (58.3) 7 (46.7) 1.60 (0,34–7.40) 0.54
Epidemiologic data
Low endemicity of infection 10 (83.3) 3 (20.0) 20.0 (2.77–144.31) 0.003 19.26 (1.12–331.82) 0.04
Low migration from
other endemic areas
2 (16.7) 10 (66.7) 0.1 (0.02–0.64) 0.015 0.57 (0.03–11.46) 0.72
Low vector density 8 (66.7) 2 (13.3) 13.0 (1.92–87.99) 0.009 11.58 (0.68–197.0) 0.09
Operational data
High treatment coverage 7 (58.3) 8 (53.3) 1.22 (0,27–5.67) 0.79 0.23 (0.01–11.28) 0.46
Optimal vectorial control 7 (58.3) 1 (6.7) 19.60 (1.91–201.62) 0.01 18.00 (0.36–894.6) 0.14
OR, odds ratio. PELF, Program for Elimination of Lymphatic Filariasis.
*A P value ,0.05 was considered to be statistically significant.
doi:10.1371/journal.pntd.0001286.t002
Table 3. Association between characteristics of villages and program related factors and PELF success to stop transmission.
Factor
Villages where PELF
succeeded
(N=19)
Villages where
PELF failed
(N=8) Univariate Analysis Multivariate Analysis
OR (95% CI) P value* OR (95% CI) P value*
Demographic data
average age ,20 yr old 6 (31.6) 3 (37.5) 0.76 (0.13–4.32) 0.76 3.19 (0.21–46.86) 0.40
sex, male-female rate .0.50 9 (47.4) 5 (62.5) 0.54 (0.1–2.93) 0.47
Epidemiologic data
Low endemicity of infection 12 (63.2) 8 (12.5) 12.00 (1.21–118.89) 0.03 27.44 (1.05–719.6) 0.04
Low migration from
other endemic areas
7 (36.8) 5 (62.5) 0.35 (0.06–1.93) 0.23
Low vector density 9 (47.4) 1 (12.5) 6.30 (0.64–61.63) 0.11 21.85 (0.61–786.3) 0.09
Operational data
High treatment coverage 9 (47.4) 6 (75.0) 0.30 (0.05–1.88) 0.20 0.08 (0.01–1.41) 0.08
Optimal vectorial control 7 (36.8) 1 (12.5) 4.08 (0.41–40.45) 0.23
OR, odds ratio. PELF, Program for Elimination of Lymphatic Filariasis.
*A P value ,0.05 was considered to be statistically significant.
doi:10.1371/journal.pntd.0001286.t003
Impact of a Filariasis Control Program
www.plosntds.org 6 August 2011 | Volume 5 | Issue 8 | e1286number of relatively skilled and affluent workers, often from areas
such as Port Moresby and other regional centres where LF
endemicity is low. Thus migration did not contribute to the
reservoir of filariasis in Lihir.
The long term impact of MDA is determined by the drugs’
effects on microfilaria, and particularly on adult worms [29]. A
single dose of DEC and Albendazole rapidly reduces the number
of circulating microfilaria, but also has a temporary effect in
reducing the production of microfilaria by adult worms, probably
due to sterilization. After some months renewed production occurs
but at a reduced intensity [20,29]. In the absence of macrofilar-
icidal activity, current programs rely on the interruption of
transmission through sustained suppression of microfilaremia over
the 5 years of a program. Experimental studies have documented
the median fecund lifespan of W. Bancrofti worms to be more than
the 5 years typical of an MDA [30]. In addition, single doses of
DEC and Albendazole have been shown to have a limited capacity
to kill the adult worm. A Brazilian study found a significant
proportion of adult worms were insensitive to DEC at doses of
6 mg/kg, with ultrasound studies showing only a 56% mortality
for adult worms after 5 years [29]. This has led some physicians to
suggest that MDA programs should be of at least the same
duration as the lifespan of adult worms. Moreover, it has been
demonstrated that individuals in areas of high endemicity will have
a higher average adult worm burden, and therefore a higher
chance of a fecund worm pair surviving after MDA is complete
[14]. A theoretical analysis with field data from 9 villages, in
distinct endemic areas, identified the degree of infection
aggregation as one of the main factors related to failure of a
PELF. Through a simulation procedure, the author estimated that
following the current approach, only 50% of programs would
achieve parasite elimination [6]. Dunyo et al. in their study
showed a higher level of microfilarial resurgence than in other
programs, and suggested that this may have been due to a high
pre-treatment worm burden [31].
The fact that successful elimination of disease in high prevalence
areas may require longer duration of MDA programmes has
already been recognized by experts [1–4,24,32–34]. This paper
provides the data that support such recommendations. It is clear
that local data needs to be taken into account when designing
MDA programs. Alternative strategies may be needed, including
modified drug regimens (e.g., biannual MDA), vector control
measures, or perhaps antibiotic treatment.
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